Postmenopausal Women With Early-stage Breast Cancer and Low Recurrence Score Could Skip Adjuvant Chemotherapy
Adjuvant chemotherapy may yield improved survival outcomes for premenopausal counterparts SAN ANTONIO – After a median follow-up of 5.1...
Search/Filter
Loading...
Omitting Radiation Therapy After Breast-Conserving Surgery May Not Impact 10-year Survival Rates for Older Patients With HR-positive Breast Cancer
SAN ANTONIO – Older patients with hormone receptor-positive breast cancer who did not receive radiation therapy after breast-conserving surgery...
Breast Cancer Survivors Are Less Likely to Get Pregnant, but Often Have Healthy Babies and Good Long-term Health
SAN ANTONIO – A large meta-analysis of breast cancer survivors of childbearing age indicated that they are less likely...
Updated monarchE Trial Data Shows Abemaciclib Continues to Benefit Patients With High-risk, HR-positive, HER2-negative, Early-stage Breast Cancer
SAN ANTONIO – Extended follow-up data from the phase III monarchE trial showed that adding the cyclin-dependent kinase (CDK)...
Award Winners Named for the 2020 San Antonio Breast Cancer Symposium
SAN ANTONIO – The San Antonio Breast Cancer Symposium (SABCS) and the American Association for Cancer Research (AACR), an...
Native American Ancestry Associated With Increased Mutations in EGFR Gene Among Latin American Patients With Lung Cancer
PHILADELPHIA – Among patients with lung cancer from Latin America, genomic and ancestry analyses revealed that Native American ancestry...
Use of Dexamethasone May Decrease the Efficacy of Immune Checkpoint Inhibitors in Patients With Glioblastoma
PHILADELPHIA – Among patients with glioblastoma receiving an immune checkpoint inhibitor, those who received the corticosteroid dexamethasone at baseline...
Daniel D. Von Hoff, MD, FACP, FASCO, FAACR, To Receive Inaugural AACR Scientific Achievement Award Established in His Honor
PHILADELPHIA – The American Association for Cancer Research (AACR) announced today that Daniel D. Von Hoff, MD, FACP, FASCO,...
FDA and AACR Launch Project Livin’ Label
PHILADELPHIA – The American Association for Cancer Research (AACR) and the U.S. Food and Drug Administration (FDA) will collaborate...
Artificial Intelligence May Help Predict Response to Immune Checkpoint Blockade in Patients With Metastatic Melanoma
PHILADELPHIA – A computational method that combines clinicodemographic variables with deep learning of pre-treatment histology images could predict response...